R
72
5
FLS
64
3
UHS
66
-5
CINF
58
-2
FOX
57
2
CFG
89
4
T
35
-3
HRL
47
2
ADBE
44
3
DE
48
5
VZ
54
2
CSX
54
4
ADP
65
4
VNO
44
-2
NWL
61
3
PVH
64
5
THC
60
-4
EW
55
-2
ICE
64
2
OKE
56
3
R
72
5
FLS
64
3
UHS
66
-5
CINF
58
-2
FOX
57
2
CFG
89
4
T
35
-3
HRL
47
2
ADBE
44
3
DE
48
5
VZ
54
2
CSX
54
4
ADP
65
4
VNO
44
-2
NWL
61
3
PVH
64
5
THC
60
-4
EW
55
-2
ICE
64
2
OKE
56
3
Financhill
Back

Sarepta Therapeutics, Inc. 10K Form

Sell
48

SRPT
Sarepta Therapeutics, Inc.

Last Price:
$22.84
Seasonality Move:
10.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SRPT News And Ratings

See the #1 stock for the next 7 days that we like better than SRPT

SRPT Financial Statistics

Sales & Book Value

Annual Sales: $1.9B
Cash Flow: $-55.6M
Price / Cash Flow: 0
Annual Sales: $12.60
Price / Book: 1.73

Profitability

EPS (TTM): -2.89240
Net Income (TTM): $-271.5M
Gross Margin: $1.5B
Return on Equity: -20.67%
Return on Assets: -7.46%

Sarepta Therapeutics, Inc. Earnings Forecast

Key Sarepta Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 29 years for SRPT is 81.24%.
  • The Selling, General & Administrative Expenses for SRPT have been equal to 29.33% of Gross Profit Margin.
  • The Research & Development expenses have been 40.93% of Revenue.
  • The Interest Expense is 7.82% of Operating Income.
  • The Net Earning history of SRPT is 12.37% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 15 years.

Sarepta Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SRPT
CUSIP: 803607
Website: sarepta.com

Debt

Debt-to-Equity Ratio: 0.95
Current Ratio: 2.95
Quick Ratio: 1.42

Price-to-Earnings

Trailing P/E Ratio: 9.34
Forward P/E Ratio: 6.62

SRPT Technical Analysis vs Fundamental Analysis

Sell
48
Sarepta Therapeutics, Inc. (SRPT) is a Sell

Is Sarepta Therapeutics, Inc. a Buy or a Sell?